Study Links Specific Brain Stimulation Frequency to Speech Speed in Parkinson's Disease
Researchers found that low-frequency deep brain stimulation (DBS) of the subthalamic nucleus in Parkinson's disease patients selectively suppresses a narrow 15–23 Hz beta frequency subband, which is negatively associated with speech tempo. This subband's activity appears to slow articulatory rate, while low-frequency stimulation improved it. The findings suggest the 15–23 Hz beta subband could serve as a neural biomarker for guiding speech-related DBS therapy in Parkinson's disease.
A study published on bioRxiv investigated how different stimulation frequencies of subthalamic nucleus deep brain stimulation (STN-DBS) affect beta oscillation dynamics in people with Parkinson's disease and their relationship to speech production. The researchers found that low-frequency stimulation (LFS) selectively attenuated power in a narrow 15–23 Hz beta subband, distinguishing it from broader beta activity. This specific subband showed a negative association with speech tempo, meaning higher power in this range corresponded to slower articulatory rates. Importantly, LFS was associated with improvements in articulatory rate, consistent with the suppression of this inhibitory subband. The authors propose that 15–23 Hz beta subband dynamics may represent a candidate neural marker for speech-tempo modulation, potentially enabling more targeted, adaptive DBS programming to address speech deficits in Parkinson's disease.
What's missing
As a preprint, this study has not yet undergone peer review, so findings should be interpreted cautiously. Key limitations likely include small sample size (typical for DBS studies), lack of detail on whether results generalize across different DBS devices or electrode placements, and whether the 15–23 Hz subband finding replicates across independent cohorts. The causal direction of the beta subband–speech tempo relationship also remains to be established, and long-term effects of LFS on speech and other motor symptoms are not addressed.
What different sources said
- bioRxivCenter
STN-DBS frequency-tuned beta subband dynamics are associated with speech tempo in Parkinson's disease
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.